FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine
News Staff
Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to:
Expand the use of a single booster dose to include use in individuals 12 through 15 years of age.
Monday, January 3, 2022